Development of Pt(IV) Conjugates of Oxaliplatin and Redox Modulators as Anticancer Agents With Reduced Neurotoxicity

Dr. Alvaro Lopez-Sanchez (Brooklyn College Cancer Center—American Cancer Society Postdoctoral Fellow, Chemistry and Biochemistry Department) discusses “Development of Pt(IV) conjugates of oxaliplatin and redox modulators as anticancer agents with reduced neurotoxicity” in this joint seminar of BCCC-CURE and the Department of Chemistry and Biochemistry, hosted by Professor Maria Contel.